日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial

新辅助帕博西尼联合内分泌治疗与化疗治疗ER+/HER2-乳腺癌:一项随机II期试验

Matikas, Alexios; Tzoras, Evangelos; Sarafidis, Michail; Sifakis, Emmanouil G; Bjöhle, Judith; Barnekow, Elin; Margolin, Sara; Isaksson-Friman, Erika; Kessler, Luisa Edman; Zouzos, Athanasios; Johansson, Hemming; Hellström, Mats; Agartz, Susanne; Grybäck, Per; Salgkamis, Dimitrios; Zerdes, Ioannis; Wang, Kang; Hartman, Johan; Acs, Balazs; Sun, Wenwen; Boyaci, Ceren; Villacampa, Guillermo; Pascual, Tomas; Gavila, Joaquin; Prat, Aleix; Perou, Charles; Brandberg, Yvonne; Bergh, Jonas; Hatschek, Thomas; Foukakis, Theodoros

Addition of Ipatasertib to Dual Anti-HER2 Maintenance Therapy in HER2-Positive Metastatic Breast Tumors with PIK3CA Mutations: The Phase Ib SOLTI-1507 IPATHER Trial

在 PIK3CA 突变的 HER2 阳性转移性乳腺癌中,将 Ipatasertib 加入双重抗 HER2 维持治疗:Ib 期 SOLTI-1507 IPATHER 试验

Oliveira, Mafalda; Ciruelos, Eva; Villacampa, Guillermo; Morales, Serafín; Salvador Bofill, Javier; Quiroga, Vanesa; Gavilá, Joaquín; Cortegoso, Alexandra; Vega, Estela; Henao, Fernando; Servitja, Sonia; Tolosa, Pablo; Chillara, Samyukta; Bergamino, Milana; Salvador, Fernando; Paes Dias, Mariana; Ferrero-Cafiero, Juan M; Gonzalez Farre, Xavier; Pascual, Tomás; Saura, Cristina

Pembrolizumab and Paclitaxel in Patients with HR+/HER2- Breast Cancer with HER2-Enriched or Basal-like Subtypes

帕博利珠单抗联合紫杉醇治疗 HR+/HER2- 乳腺癌患者,包括 HER2 富集型或基底样亚型

Conte, Benedetta; Brasó-Maristany, Fara; Pascual, Tomás; Hernando, Cristina; Vázquez, Silvia; Blanch, Salvador; Oliveira, Mafalda; Virizuela, Juan Antonio; Muñoz, Montserrat; Seguí, Elia; Rodriguez-Hernandez, Adela; Vidal Losada, Maria Jesus; Galván, Patricia; Castillo, Oleguer; Blasco, Paula; Alva, Manuel; Chic, Nuria; Sanfeliu, Esther; Cano-Crespo, Sara; Salvador, Fernando; Villacampa, Guillermo; Villanueva, Lorea; Ferrero-Cafiero, Juan Manuel; Vivancos, Ana; Prat, Aleix; Ciruelos, Eva

Validation of the HER2DX genomic test in first-line advanced HER2-positive breast cancer treated with trastuzumab, pertuzumab, and taxane

验证 HER2DX 基因组检测在接受曲妥珠单抗、帕妥珠单抗和紫杉烷一线治疗的 HER2 阳性晚期乳腺癌患者中的应用价值

Kubeczko, Marcin; Cobo, Sandra; Sanchez-Bayona, Rodrigo; Pyciński, Bartłomiej; Soberino, Jesús; Chmielik, Ewa; Sanfeliu, Esther; Rey, Maria; Pardo, Francisco; Aguirre, Angela; Castillo, Oleguer; Lesniak, Aleksandra; Oczko-Wojciechowska, Malgorzata; Carcelero, Esther; Adamo, Barbara; Vidal, Maria; Bergamino, Milana; Maues, Julia; Villacampa, Guillermo; Paré, Laia; Villagrasa, Patricia; Ciruelos, Eva; Prat, Aleix; Jarzab, Michal; Brasó-Maristany, Fara

RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer.

RAD51 同源重组缺陷与早期乳腺癌的治疗反应和生存率相关。

Llop-Guevara Alba, Pellegrino Benedetta, Pimentel Isabel, Villacampa Guillermo, Solinas Cinzia, Torres-Esquius Sara, Campanini Nicoletta, Simonetti Sara, Tommasi Chiara, Serra Olga, Corianò Matilde, Boggiani Daniela, Michiara Maria, Minari Roberta, Bortesi Beatrice, Rapacchi Elena, Dieci Maria Vittoria, Lambertini Matteo, Zoppoli Gabriele, Schirone Alessio, Casarini Chiara, Cretella Elisabetta, Cortesi Laura, Silini Enrico Maria, Saura Cristina, Willard-Gallo Karen, Boisson Anais, Musolino Antonino, Serra Violeta, Balmaña Judith, Cruz Cristina

Cost-Effectiveness Analysis of Aztreonam-Avibactam Compared with Colistin Plus Meropenem in Treating Metallo-Beta-Lactamase-Producing Enterobacterales Infections in Spain

西班牙治疗产金属β-内酰胺酶肠杆菌感染中,氨曲南-阿维巴坦与粘菌素联合美罗培南的成本效益分析

Aguilar, Gerardo; Ruiz-Garbajosa, Patricia; Periañez Parraga, Leonor; Maroto-Díaz, Marta; de Ceano-Vivas, María Del Carmen; Villacampa Lordan, Alba; Arranz Gonzalo, Sara; de Lossada Juste, Alfonso; Moya-Alarcón, Carlota; Gheorghe, Maria; Torre-Cisneros, Julián

Aggressive prostate cancer is associated with pericyte dysfunction.

侵袭性前列腺癌与周细胞功能障碍有关。

Martinez-Romero Anabel, Martinez-Larrinaga Ane, Grego-Bessa Joaquim, Garcia-Longarte Saioa, van Splunder Hielke, Astobiza Ianire, Ercilla Amaia, Bozal-Basterra Laura, Mendizabal Isabel, Villacampa Pilar, Carracedo Arkaitz, Graupera Mariona

A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer - The MONEO Study

一项针对可切除胃癌或胃食管交界处癌患者的围手术期阿维鲁单抗联合化疗的II期研究——MONEO研究

Alsina, Maria; Villacampa, Guillermo; de Andrea, Carlos; Vivancos, Ana; Ponz-Sarvise, Mariano; Arrazubi, Virginia; Jimenez-Fonseca, Paula; Diez, Marc; Sanz-Garcia, Enrique; Martínez, Eva; Guardeño, Raquel; Calvo, Mariona; Bugés, Cristina; Longo, Federico; Navarro, Víctor; García-Galea, Eduardo; Gros, Alena; Ochoa, Maria C; Lopez-Janeiro, Alvaro; Sanchez-Gregorio, Sandra; Herrero, Claudia; Labiano, Ibone; Vila-Casadesús, Maria; López, Dario; Alexandru, Raluca; Muñoz, Susana; Tabernero, Josep; Melero, Ignacio

Adjuvant endocrine treatment strategies for non-metastatic breast cancer: a network meta-analysis

非转移性乳腺癌辅助内分泌治疗策略:一项网络荟萃分析

Papakonstantinou, Andri; Villacampa, Guillermo; Navarro, Victor; Oliveira, Mafalda; Valachis, Antonios; Pascual, Tomas; Matikas, Alexios

SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols

SPIRIT-DEFINE 解释和阐述:提高早期剂量探索临床试验方案质量和影响的建议

Ursino, Moreno; Villacampa, Guillermo; Rekowski, Jan; Dimairo, Munyaradzi; Solovyeva, Olga; Ashby, Deborah; Berlin, Jordan; Boix, Oliver; Calvert, Melanie; Chan, An-Wen; Coschi, Courtney H; Evans, Thomas R Jeffry; Garrett-Mayer, Elizabeth; Golub, Robert M; Guo, Christina; Hayward, Kathryn S; Hopewell, Sally; Isaacs, John D; Ivy, S Percy; Jaki, Thomas; Kholmanskikh, Olga; Kightley, Andrew; Lee, Shing; Liu, Rong; Mander, Adrian; Marshall, Lynley V; Matcham, James; Patel, Dhrusti; Peck, Richard; Rantell, Khadija Rerhou; Richards, Dawn P; Rouhifard, Mahtab; Seymour, Lesley; Tanaka, Yoshiya; Weir, Christopher J; de Bono, Johann; Yap, Christina